151 related articles for article (PubMed ID: 16622558)
1. [Olfactory groove meningioma: correlation between clinicoradiological features and proliferative index (Mib-1)].
Paiva Neto MA; Tella OI; Herculano MA; Stávale JN; Bonatteli AP
Arq Neuropsiquiatr; 2006 Mar; 64(1):77-82. PubMed ID: 16622558
[TBL] [Abstract][Full Text] [Related]
2. Meningioma: proliferating potential and clinicoradiological features.
Nakasu S; Nakajima M; Matsumura K; Nakasu Y; Handa J
Neurosurgery; 1995 Dec; 37(6):1049-55. PubMed ID: 8584144
[TBL] [Abstract][Full Text] [Related]
3. MIB-1 staining index and peritumoral brain edema of meningiomas.
Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
Cancer; 1996 Jul; 78(1):133-43. PubMed ID: 8646709
[TBL] [Abstract][Full Text] [Related]
4. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
[TBL] [Abstract][Full Text] [Related]
5. Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning.
Mantle RE; Lach B; Delgado MR; Baeesa S; Bélanger G
J Neurosurg; 1999 Sep; 91(3):375-83. PubMed ID: 10470810
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of olfactory groove meningiomas.
Obeid F; Al-Mefty O
Neurosurgery; 2003 Sep; 53(3):534-42; discussion 542-3. PubMed ID: 12943570
[TBL] [Abstract][Full Text] [Related]
7. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
[TBL] [Abstract][Full Text] [Related]
8. Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.
Prat-Acín R; Guarín-Corredor MJ; Galeano-Senabre I; Ayuso-Sacido A; Vera-Sempere F
J Clin Neurosci; 2021 Apr; 86():32-37. PubMed ID: 33775343
[TBL] [Abstract][Full Text] [Related]
9. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the proliferative potential of meningiomas with MIB-1 monoclonal antibodies].
Miyagami M; Shibuya T; Miyagi A; Tsubokawa T
No To Shinkei; 1996 Jan; 48(1):39-43. PubMed ID: 8679317
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
[TBL] [Abstract][Full Text] [Related]
12. Absence of histological signs of tumor progression in recurrences of completely resected meningiomas.
Schiffer D; Ghimenti C; Fiano V
J Neurooncol; 2005 Jun; 73(2):125-30. PubMed ID: 15981101
[TBL] [Abstract][Full Text] [Related]
13. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
[TBL] [Abstract][Full Text] [Related]
15. Pericytosis and edema generation: a unique clinicopathological variant of meningioma.
Robinson JC; Challa VR; Jones DS; Kelly DL
Neurosurgery; 1996 Oct; 39(4):700-6; discussion 706-7. PubMed ID: 8880761
[TBL] [Abstract][Full Text] [Related]
16. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas.
Abramovich CM; Prayson RA
Arch Pathol Lab Med; 1999 Sep; 123(9):793-800. PubMed ID: 10458826
[TBL] [Abstract][Full Text] [Related]
18. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
Abramovich CM; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
[TBL] [Abstract][Full Text] [Related]
19. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
Abry E; Thomassen IØ; Salvesen ØO; Torp SH
Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
[TBL] [Abstract][Full Text] [Related]
20. Analysis of factors affecting the long-term functional outcome of patients with skull base meningioma.
Nakao N; Ohkawa T; Miki J; Nishibayahsi H; Ogura M; Uematsu Y; Itakura T
J Clin Neurosci; 2011 Jul; 18(7):895-8. PubMed ID: 21565513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
